**Core Concept:** Oral hypoglycemic agents are medications used in the management of diabetes mellitus. They include both sulfonylureas and biguanides as main classes, with other classes like thiazolidinediones, meglitinides, and alpha-glucosidase inhibitors being used as well.

**Why the Correct Answer is Right:** Sulfonylureas are a class of oral hypoglycemic agents that stimulate insulin release from pancreatic beta cells. They act on the sulfonylurea receptors, which are found on pancreatic beta cells. This receptor activation leads to an increase in intracellular cyclic adenosine monophosphate (cAMP) production, which in turn activates protein kinase A, facilitating the translocation of glucose transporter type 2 (GLUT2) to the plasma membrane, allowing glucose uptake into the beta cells. Ultimately, this results in increased insulin secretion and improved glucose homeostasis.

**Why Each Wrong Option is Incorrect:**

A. **Not a correct answer:** This option does not represent an oral hypoglycemic agent.
B. **Not a correct answer:** This option is related to insulin, not oral hypoglycemic agents.
C. **Incorrect answer type:** This is a clinical scenario instead of a specific oral hypoglycemic agent.
D. **Not a correct answer:** This option is related to insulin, not oral hypoglycemic agents.

**Clinical Pearl:** In the management of type 2 diabetes, oral hypoglycemic agents are usually combined to achieve better glycemic control, particularly when used in combination with insulin or other injectable medications. This combination therapy allows for more personalized treatment plans based on individual patient needs and responses.